Abstract:Background This study generalized and analyzed the clinical attributes observed in patients afflicted with Kaposiform hemangioendothelioma (KHE) with the aim of elucidating the risk factors contributing to the manifestation of Kasabach-Merritt phenomenon (KMP). Methods We retrospectively analyzed 96 pediatric cases diagnosed with KHE at the Children's Hospital of Fudan University from January 2013 to December 2021. Among them, 62 patients (65%) showed KMP (KHE+KMP group), while 34 patients (35%) did not (KHE-KMP group). The risk factors for KMP associated with KHE were analyzed using univariate analysis and binary logistic regression analysis, comparing the differences between KHE+KMP group and KHE-KMP group. Results Univariate analysis indicated no statistically significant differences between the two groups in gender, prematurity, family history, or color of involved skin. However, statistically significant differences were observed in age of onset, lesion site, and lesion depth. Multivariate analysis revealed significant associations: children with onset age ≤1 month had a 51-fold increased risk of KMP compared to those with onset age >1 month (95% CI 5.238-501.663); non-extremity lesion sites exhibited a 21-fold higher risk of KMP compared to extremity sites (95% CI 3.970-105.958); deeper lesions conferred a 5-fold higher risk of KMP compared to superficial lesions (95% CI 1.073-21.005); lesions >60 mm carried a 17-fold higher risk of KMP compared to lesions ≤60 mm (95% CI 2.999-96.157).A comprehensive predictive model was developed using the fitting formula: Logit (P) = 3.937*(age at onset) + 1.558*(lesion depth) + 3.021*(lesion site) + 2.832*(lesion size), demonstrating an accuracy of 82.9%. Furthermore, a scoring system was established to assess the likelihood of KMP occurrence. Children diagnosed with KHE were likely to have KMP if their score exceeded 72.5, as determined by Receiver Operating Characteristic (ROC) curve analysis. Conclusion Age of onset ≤1 month, deeper lesions, non-extremity sites, and lesions >60 mm are independent risk factors for KMP in children with KHE. The cumulative presence of these factors escalates the likelihood of KMP development. Additionally, the identification of these factors allows for the early recognition of potential KMP cases among children with KHE, facilitating prompt therapeutic intervention. Category of the manuscript Clinical Research article Level of evidence LEVEL III

Expression pattern and significance of Akt/mTOR pathway-related proteins in Kasabach-Merritt syndrome

The Significance of STAT3 and MAPK Phosphorylation and Cyclind1 Protein Expression in Skin Squamous Cell Carcinoma

Roles of mTOR and p-mTOR in gastrointestinal stromal tumors.

Clinical Significance of Stat3 and Mapk Phosphorylation, and the Protein Expression of Cyclin D1 in Skin Squamous Cell Carcinoma Tissues

Proteomic Approach to Substrates Related to MAPK Pathway in 293T Cells

Analysis of risk factors for Kasabach Merritt phenomenom in children with Kaposiform Hemangioendothelioma

Association of the Activation of the Mtor Pathway with Prognosis in Chinese Melanoma Patients.

Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki Syndrome

Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation

[Expressions of Survivin, PI3K and AKT in Keratinocytes in Skin Lesions and Their Pathogenic Role in Psoriasis Vulgaris].

Imbalanced Expression of Mitogen-Activated Protein Kinase Phosphatase-1 and Phosphorylated Extracellular Signal-Regulated Kinases in Lung Squamous Cell Carcinoma

RAP1-mediated MEK/ERK Pathway Defects in Kabuki Syndrome.

Comparison of Akt/mammalian target of rapamycin/4E-binding protein 1 pathway signal activation in round stromal and surface cells in patients with sclerosing pneumocytoma

A Signal Transduction Pathway From Tgf-Beta 1 To Skp2 Via Akt1 And C-Myc And Its Correlation With Progression In Human Melanoma

Progress in Kasabach-Merritt Syndrome

The candidate proteins associated with keratoconus: A meta-analysis and bioinformatic analysis

Expression of Mtor Signaling Pathway Proteins in Gliomas and Its Clinical Significance

Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma

Activation and Clinicopathologic Significance of AKT/mTOR Signaling Pathway in Diffuse Large B-cell Lymphoma

Proteomic Screening and Verification of Biomarkers in Different Stages of Mycosis Fungoides: A pilot Study

Gene Expression Patterns of Cutaneous Squamous Cell Carcinoma and Actinic Keratosis: Biomarkers Screening for Skin Disease Diagnosis